Summary
Patents** intestinal permeability assays (WP-3), antibody-based kits for GLP-1 (WP2), human oxidized albumin(WP4) and markers of liver damage (WP3) or IR-based methodologies to stratify NAFLD (WP3).
Managed by WP7
More information & hyperlinks